Novartis AG (NVSEF) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - General Branche. Der Hauptsitz des Unternehmens ist in Basel, Switzerland. Der aktuelle CEO ist Vasant Narasimhan.
NVSEF hat IPO-Datum 2010-04-26, 75,883 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $298.59B.
Novartis AG is a global healthcare company headquartered in Basel, Switzerland, that researches, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two primary segments: Innovative Medicines, which offers prescription medications across therapeutic areas including ophthalmology, neuroscience, immunology, cardiovascular, and respiratory medicine, and Sandoz, a leading generics and biosimilars business that manufactures and markets finished pharmaceuticals, active ingredients, and biotechnology-based products. Novartis maintains strategic collaborations with companies such as Alnylam Pharmaceuticals and Kura Oncology to advance its pipeline in areas like RNA interference therapeutics and oncology. The company serves patients, healthcare providers, and third-party pharmaceutical manufacturers across diverse markets globally.
